Fecal Galectin-3: A New Promising Biomarker for Severity and Progression of Colorectal Carcinoma

Table 1

Baseline characteristics of patients.

	Number
Colorectal carcinoma (CRC)
Gender (male/female)	35/25
Age (mean (range))	64 (50–82) years
Site (P/D/R)	15/34/11
Nuclear grade (I/II/III)	8/37/15
Histological differentiation rate  (well/moderate/poor)	11/33/16
Stage (TNM: I/II/III/IV)	42/0/16/12
Necrosis (well/moderate/absent)	16/44/0
Ulcerative colitis (UC)
Gender (male/female)	29/21
Age (mean (range))	55 (23–73) years
Endoscopic score (0/I/II/III)	0/26/16/8
Clinical score (0/I/II/III)	0/28/14/8
Crypt destruction (0/I/II/III)	4/25/9/12
Erosion of the mucous membranes (0/I/II/III/IV)	12/13/6/9/10
Architectural changes (0/I/II/III)	0/23/14/13
Neutrophil infiltration (0/I/II/III)	5/19/8/18
Eosinophil infiltration (0/I/II/III)	10/16/13/11

P: proximal colon; D: distal colon; R: rectum.